SCHEMBL5336401

SCHEMBL5336401

Cc1ccc2cc(C(CC=O)C3CCN(Cc4ccccc4)CC3)n(S(=O)(=O)c3ccccc3)c2c1

nearest known ligand 0.42

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 2/20 0.42
ALDH1A1 P00352 4/20 0.41
KDM4E B2RXH2 1/20 0.41
HTR2A P28223 1/20 0.40
HTR6 P50406 2/20 0.40
KMT2A Q03164 1/20 0.40
DRD2 P14416 2/20 0.40
LMNA P02545 1/20 0.40
TSHR P16473 1/20 0.40
DRD4 P21917 1/20 0.38
CD4 P01730 1/20 0.38
SORT1 Q99523 1/20 0.38
ACHE P22303 1/20 0.38
PKM P14618 1/20 0.38
CCR4 P51679 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7594219 0.88 SMN1; SMN2 (0.46) SMN1; SMN2ALDH1A1KDM4EHTR2AHTR6
SCHEMBL7594215 0.82 SMN1; SMN2 (0.47) SMN1; SMN2ALDH1A1HTR2ALMNATSHR
SCHEMBL7865669 0.80 SMN1; SMN2 (0.44) SMN1; SMN2ALDH1A1KDM4EHTR2AHTR6
SCHEMBL4710254 0.78 BACE1 (0.41) LMNAACHE
SCHEMBL7598488 0.76 SMN1; SMN2 (0.46) SMN1; SMN2ALDH1A1HTR2AHTR6DRD2
SCHEMBL7598485 0.76 SMN1; SMN2 (0.46) SMN1; SMN2ALDH1A1HTR2AHTR6DRD2
SCHEMBL9383745 0.75 ITK (0.45) DRD2LMNADRD4ACHE
SCHEMBL9387794 0.74 ALDH1A1 (0.45) SMN1; SMN2ALDH1A1KDM4EHTR2AHTR6
SCHEMBL7598492 0.74 ALDH1A1 (0.47) SMN1; SMN2ALDH1A1HTR2AHTR6LMNA
SCHEMBL251631 0.74 ACHE (0.53) SMN1; SMN2DRD2DRD4ACHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1853590-A1 FUSED HETEROCYCLIC COMPOUNDS AND THEIR USE AS SIRTUIN MODULATORS Sirtris Pharmaceuticals, Inc. (US) 2007-11-14 EP disclosed
WO-2006094235-A1 FUSED HETEROCYCLIC COMPOUNDS AND THEIR USE AS SIRTUIN MODULATORS SIRTRIS PHARMACEUTICALS, INC. (US) 2006-09-08 WO disclosed